Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Female Pelvic Med Reconstr Surg. 2016 Sep-Oct;22(5):311–316. doi: 10.1097/SPV.0000000000000277

Figure 2. Percentage of ABC study sample with adequate symptom control, by treatment group, months 2 through 9.

Figure 2

Note: Months 7 through 9 in the Botox group are actual observed values. Months 7 through 9 in the Anticholinergic group are assumed values based on maintaining efficacy present at the 6-month time period.